Synthesis and Biological activity of kappa opioid receptor agonists. Part 2: Preparation of 3-aryl-2-pyridone analogues generated by solution- and solid-phase parallel synthesis methods

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 6, 2003, Pages 1141-1145

  Semple, Graeme ^a,b   Andersson, Britt Marie ^a   Chhajlani, Vijay ^a   Georgsson, Jennie ^a   Johansson, Magnus J ^a   Rosenquist, Åsa ^a   Swanson, Lars ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b ARENA PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAPPA OPIATE RECEPTOR AGONIST; OPIATE RECEPTOR; PYRIDONE DERIVATIVE;

ARTICLE; BUCHWALD REACTION; CHEMICAL REACTION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; MITSUNOBU REACTION; STRUCTURE ACTIVITY RELATION; SUZUKI REACTION;

LATEOLABRAX JAPONICUS;

EID: 0037463770     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00033-7     Document Type: Article

References (17)

1. Semple G., Andersson B.M., Chhajlani V., Georgsson J., Johansson M., Lindschoten M., Pontén F., Rosenquist Å., Sörenson H., Swanson L., Swanson M. Bioorg. Med. Chem. Lett. 12:2002;197.
2. Clark D.E. J. Pharm. Sci. 88:1999;815.
3. Rimoy G.H., Wright D.M., Bhaskar N.K., Rubin P.C. Eur. J. Clin. Pharmacol. 46:1994;203.
4. Jones R.G. J. Am. Chem. Soc. 71:1949;78.
5. Breukelman S.P., Meakins G.D., Roe A.M. J. Chem. Soc., Perkin Trans. 1. 1985;1627.
6. Kress T.J. J. Org. Chem. 50:1985;3073.
7. 125I]-Deltorphin (δ).
8. 35S]-GTPγS assay, again using membranes of HEK-293 cells overexpressing the human kappa opioid receptor.
9. Shapiro S.L., Soloway H., Freedman L. J. Am. Chem. Soc. 80:1958;6060.
10. Pelletier J.C., Kincaid S. Tetrahedron Lett. 41:2000;797 Barrett A.G.M., Roberts R.S., Schroder J. Org. Lett. 2:2000;2999.
11. Pelletier J.C., Kincaid S. Tetrahedron Lett. 41:2000;797 Barrett A.G.M., Roberts R.S., Schroder J. Org. Lett. 2:2000;2999.
12. Comins D.L., Jianhua G. Tetrahedron Lett. 35:1994;2819.
13. Costello G.F., James R., Shaw J.S., Slater A.M., Stutchbury N.C.J. J. Med. Chem. 34:1991;181.
14. Shaw J.S., Carroll J.A., Alcock P., Main B.G. Br. J. Pharmacol. 96:1989;986.
15. 3 and R-BINAP, were placed in each well of a dry Robbins block. Dry dioxan was added and the block sealed and agitated under argon for 18 h at 90°C. The reaction mixtures were filtered thorough silica plugs (eluting with 0.2% ammonia in EtOAc), and then purified by ion exchange on pre-packed SCX columns.
16. 16 and its des-hydroxy analogue showed that the former is around 10-fold more potent in both binding and function at the KOR. In addition it is the S-isomer at the hydroxyl position which is most active.
17. Barber A., Bartoszyk G.D., Bender H.M., Gottschlich R., Greiner H.E., Harting J., Mauler F., Minck K.O., Murray R.D., Simon M. Br. J. Pharmacol. 113:1994;1317.